Pathogenesis of focal glomerulosclerosis

Nephron

Volumn 88, Issue 1, 2001, Pages 6-13

  Bolton, W Kline ^a   Abdel Rahman, Emaad ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

End stage renal disease; Focal segmental glomerulosclerosis; Nephrotic syndrome; Proteinuria

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOMODULATING AGENT; MYCOPHENOLIC ACID;

ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; RISK FACTOR;

GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROTIC SYNDROME; PROTEINURIA;

EID: 0035021508     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045952     Document Type: Article

References (42)

1. Munk F: Pathologie und Klinik der Nephrosen, Nephritiden und Schrumpfnieren. Urban and Schwarzenberg, 1918.
2. Rich AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957;100: 173-183.
3. Habib R: Focal glomerular sclerosis. Kidney Int 1973;4:355-361.
4. Grishman E, Churg J: Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes. Kidney Int 1975;7:111-122.
5. Rennke HG, Klein PS: Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989; 13: 443-456.
6. Korbet SM: Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 1998;9:1333-1340.
7. Harris RC: Molecular basis of injury and progression in focal glomerulosclerosis. Nephron 1999;82:289-299.
8. Bhathena D, Weiss JH, Holland NH, McMorrow RG, Curtis JJ, Lucas BA, Luke RG: Focal and segmental glomerular sclerosis in reflux nephropathy. Am J Med 1980;68:886-892.
9. Schachter AD, Strom TB: Posttransplant recurrent FSGS: Molecular insights and future directions. Nephron 1999;82:300-305.
10. Weiss MA, Daquioag E, Margolin EG, Pollack VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular 'collapse': A new clinicopathologic entity? Am J Kidney Dis 1986;7:720-728.
11. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 1996;50:1734-1746.
12. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999;10:51-61.
13. Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A: Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998;53:918-925.
14. Schwartz MM, Evans J, Bain RP, Korbet SM: Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion (abstract). J Am Soc Nephrol 1999;10:1900-1907.
15. Magil A, Cohen AH: Monocytes and focal glomerulosclerosis. Lab Invest 1989;61:404-409.
16. Kriz W, Hartmann I, Hahnel B, Hosser H, Provoost A, Kranzlin B, Gretz N: Tracer studies in rat models of focal segmental glomerulosclerosis (FSGS) demonstrate misdirected filtration and filtrate spreading in injured nephrons (abstract). J Am Soc Nephrol 1999;10:662A.
17. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifet RA, Bowmen-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297-309.
18. Floege J, Kriz W, Schulze M, Susani M, Kerjaschki D, Mooney A, Couser WG, Koch KM: Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 1995;96:2809-2819.
19. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-2601.
20. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
21. Kai T, Kino H, Ishikawa K: Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes. Hypertens Res 1998; 21:39-46.
22. Eddy AA, Giachelli CM, McCullouch L, Liu E: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995; 47:1546-1557.
23. Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 1999; 33:1004-1010.
24. Bohle MW, Held H, Schumm G, Kendziorra H, Pressler H: Long-term prognosis of focal sclerosing glomerulonephritis: An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990;33:115-122.
25. Brown CB, Cameron JS, Turner DR, Chantier C, Ogg CS, Williams DG, Bewick M: Focal segmental glomerulosclerosis with rapid decline in renal function ('malignant FSGS'). Clin Nephrol 1978;10:51-61.
26. Cattran D, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998;32: 72-79.
27. Kikuta Y, Yoshimura Y, Saito T, Ishihara T, Yokoyama S, Hayashi T: Nephrotic syndrome with diffuse mesangial sclerosis in identical twins. J Pediatr 1983;102:586-589.
28. Winn MP, Conlon PJ, Lynn KL, Howell DN, Gross DA, Rogala AR, Smith AH, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, Vance JM: Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. Kidney Int 1999;55:1241-1246.
29. Conlon PJ, Lynn K, Winn MP, Quarles LD, Bembe M, Pericak-Vance MA, Speer M, Howell DN: Spectrum of disease in familial focal and segmental glomerulosclerosis. Kidney Int 1999;56:1863-1871.
30. Vats AN, Nayak A, Ellis D, Randhawa PS, Ferrell RE: High prevalance of childhood familial idiopathic nephrotic syndrome in Pittsburgh area and linkage of one large family to 19q13 (abstract). J Am Soc Nephrol 1999;10:444A.
31. Kopp JB, Branton MH, Briggs WA, Vlahov D, Korbet SM, Kimmel PL, Dart RA, Berns JS, Welch TR, Smith MC, Schelling JR, Simon EE, Ahuja TS, Wachter L, Nelson G, Winkler C: Genetic analysis of focal segmental glomerulosclerosis among African Americans (abstract). J Am Soc Nephrol 1999;10:439A.
32. Winn MP, Conlon PJ, Lynn K, Howell DN, Slotterbeck BD, Smith A, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, Vance JM: Linkage of a gene causing familial focal segmental glomerulosclerosis in chromosome 11 and further evidence of genetic heterogeneity (abstract). J Am Soc Nephrol 1999;10:444A.
33. Tsukaguchi H, Kim SH, Abreu P, Pereira A, Pollak M: Adult onset familial FSGS mapping to chromosome 1q (abstract). J Am Soc Nephrol 1999;10:443.
34. Korbet SM, Genchi RM, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 1996;27:647-651.
35. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis EN, Lovell H, Warady B, Gunwar S, Chonko AM: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334:878-883.
36. Sharma M, Sharma R, McCarthy ET, Savin VJ: 'The FSGS factor': Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999; 10:552-561.
37. Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B: A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine 1975;23:37-40.
38. Bakker WW, Baller JFK, van Luyk WHJ, van der Hem GK: Mononuclear blood cells from patients with minimal change nephrotic syndrome (MCNS) induce increased glomerular permeability in the rat kidney in vivo (abstract). Kidney Int 1986;30:633.
39. Levin M, Gascione P, Turner MW, Barratt TM: A highly cationic protein in plasma and urine of children with steroid-responsive nephrotic syndrome. Kidney Int 1989;36:867-877.
40. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF: Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972;ii:343-348.
41. Rao TKS, Flippone EJNAD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984;310:669-673.
42. Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ: Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron 1999;81:37-40.